Clinical Trial 3211

DeLand, FL 32720


Study Summary:

Flexible-dose titration followed by a randomized double-blind study of controlled-release OROS Hydromorphone compared to placebo in patients with Osteoarthritis Pain.


Qualified Participants Must:

• Have a primary diagnosis of OA of knee or hip joint for at least past 6 months
• Be 30-80 years of age
• Require daily opioid analgesics including Tramadol for OA for at least the past 2 months


Qualified Participants May Receive:

Up to $700 upon completion of the study. The study is 12 weeks long and requires 11 office visits.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.